Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 147, Issue 2
March 2024
Acta Haematologica Cover Image for Volume 147, Issue 2
All Issues
ISSN 0001-5792
EISSN 1421-9662
In this Issue

Acta Haematologica 2024, Vol. 147, No. 2
Current Developments in Acute Myeloid Leukemia

Prelims
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (2): 115–118. https://doi.org/10.1159/000538309
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Editorial

Untangling Complexities of Acute Myeloid Leukemia Review Series
Subject Area: Hematology , Oncology
Shai Shimony; Richard M. Stone
Acta Haematol (2024) 147 (2): 119–121. https://doi.org/10.1159/000535574
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Review

Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems?
Subject Area: Hematology , Oncology
Karen-Sue Carlson; Ashley Cunningham; Maximilian Stahl; Eric Winer; Laura C. Michaelis
Acta Haematol (2024) 147 (2): 122–132. https://doi.org/10.1159/000535607
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia
Subject Area: Hematology , Oncology
Amanda L. Blackmon; Christopher S. Hourigan
Acta Haematol (2024) 147 (2): 133–146. https://doi.org/10.1159/000535463
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Optimal Post-Remission Consolidation Therapy in Patients with AML
Subject Area: Hematology , Oncology
Carlos Jimenez-Chillon; Richard Dillon; Nigel Russell
Acta Haematol (2024) 147 (2): 147–158. https://doi.org/10.1159/000535457
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Non-Immunotherapy Approaches for Relapsed or Refractory AML: An Update for 2024
Subject Area: Hematology , Oncology
Shira Buchrits; Ofir Wolach
Acta Haematol (2024) 147 (2): 159–174. https://doi.org/10.1159/000534897
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Current Guidelines, Therapies, and Future Considerations
Subject Area: Hematology , Oncology
Jeremy DiGennaro; David A. Sallman
Acta Haematol (2024) 147 (2): 175–185. https://doi.org/10.1159/000535628
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Fluoroquinolone Prophylaxis during Conventional Chemotherapy or Hematopoietic Stem Cell Transplantation for Acute Leukemia – Pros and Cons
Subject Area: Hematology , Oncology
Tomer Hoffman; Alaa Atamna; Vladislav Litchevsky; Irina Amitai; Dafna Yahav
Acta Haematol (2024) 147 (2): 186–197. https://doi.org/10.1159/000535119
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Subject Area: Hematology , Oncology
Evan C. Chen; Jacqueline S. Garcia
Acta Haematol (2024) 147 (2): 198–218. https://doi.org/10.1159/000533990
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Geriatric Assessment in Acute Myeloid Leukemia
Subject Area: Hematology , Oncology
Justin D. Woods; Heidi D. Klepin
Acta Haematol (2024) 147 (2): 219–228. https://doi.org/10.1159/000535500
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Pathophysiology of Acute Myeloid Leukemia
Subject Area: Hematology , Oncology
Franziska Wachter; Yana Pikman
Acta Haematol (2024) 147 (2): 229–246. https://doi.org/10.1159/000536152
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Obituary

In Memoriam: Isaac Ben-Bassat (1937–2023) A Lifelong Legacy in Hematology
Subject Area: Hematology , Oncology
Pia Raanani
Acta Haematol (2024) 147 (2): 247–248. https://doi.org/10.1159/000535013
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Erratum

Erratum - Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (2): 249. https://doi.org/10.1159/000537722
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

PharmaForum

Momelotinib bei Myelofibrose und Anämie
Subject Area: Hematology , Oncology
Acta Haematol (2024) 147 (2): 251–253. https://doi.org/10.1159/000538289
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
AI Applications in Transfusion Medicine: Opportunities, Challenges, and Future Directions
Favorable rates of cardiovascular events with stringent cardiovascular monitoring and a lowered dose of ponatinib as second line treatment in chronic phase chronic myeloid leukemia (CML-CP) patients failing or intolerant to first-line second generation tyrosine kinase inhibitor (TKI) treatment: Results of the prospective PONS trial
Dose reduced induction therapy (A)-AIDA in patients with AML, being unfit for standard 7+3 chemotherapy and Literature Review of AML treatment in unfit/older AML patients
Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia
  • Online ISSN 1421-9662
  • Print ISSN 0001-5792
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal